Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: A population-based study

Cancer

Volumn 120, Issue 9, 2014, Pages 1338-1344

  Lee, Yuan Wen ^a,b,c   Chen, Ta Liang ^b,c   Shih, Yu Ru Vernon ^d   Tsai, Chu Lin ^e   Chang, Chuen Chau ^b,c   Liang, Hung Hua ^b,c   Tseng, Sung Hui ^b   Chien, Shu Chen ^a   Wang, Ching Chiung ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

breast cancer; complementary and alternative medicine; National Health Insurance Research Database; taxane; traditional Chinese medicine

Indexed keywords

BAI HUA SHE SHE CAO; BAN XIA; BAN ZHI LIAN; CHINESE DRUG; GUI PI TANG; HUANG QI; JI XUE TENG; JIA WEI XIAO YAO SAN; PU GONG YING; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURVIVAL; CHINESE HERB; CHINESE MEDICINE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVIA MILTIORRHIZA; TREATMENT DURATION;

BREAST CANCER; COMPLEMENTARY AND ALTERNATIVE MEDICINE; NATIONAL HEALTH INSURANCE RESEARCH DATABASE; TAXANE; TRADITIONAL CHINESE MEDICINE;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PHYTOTHERAPY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAIWAN; TAXOIDS;

EID: 84899488239     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28579     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD,. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012; 36: 237-248.
3. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G,. Breast cancer. Lancet. 2005; 365: 1727-1741.
4. Saquib J, Madlensky L, Kealey S, et al. Classification of CAM use and its correlates in patients with early-stage breast cancer. Integr Cancer Ther. 2011; 10: 138-147.
5. Templeton AJ, Thurlimann B, Baumann M, et al. Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors. BMC Cancer. 2013; 13: 153.
6. Jacobson JS, Workman SB, Kronenberg F,. Research on complementary/ alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol. 2000; 18: 668-683.
7. Chen Z, Gu K, Zheng Y, Zheng W, Lu W, Shu XO,. The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med. 2008; 14: 1049-1055.
8. Fasching PA, Thiel F, Nicolaisen-Murmann K, et al. Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer. 2007; 15: 1277-1284.
9. Cohen I, Tagliaferri M, Tripathy D,. Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol. 2002; 29: 563-574.
10. Hsiao WL, Liu L,. The role of traditional Chinese herbal medicines in cancer therapy-from TCM theory to mechanistic insights. Planta Med. 2010; 76: 1118-1131.
11. Zhang M, Liu X, Li J, He L, Tripathy D,. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. Cochrane Database Syst Rev. 2007;(2):CD004921.
12. Lai JN, Wu CT, Wang JD,. Prescription pattern of chinese herbal products for breast cancer in taiwan: a population-based study. Evid Based Complement Alternat Med. 2012; 2012: 891893.
13. Bureau of National Health Insurance. Universal Health Coverage in Taiwan. nhi.gov.tw/Resource/webdata/21717-1-20120808UniversalHealthCoverage.pdf. Accessed June 19, 2013.
14. National Health Research Institutes. National Health Insurance Research Database. nhird.nhri.org.tw/date-01.html. Accessed June 19, 2013.
15. Kang JH, Lin HC,. Comorbidity profile of poliomyelitis survivors in a Chinese population: a population-based study. J Neurol. 2011; 258: 1026-1033.
16. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457-481.
17. Peto R, Peto J,. Asymptotically efficient rank invariant test procedures. J R Stat Soc A. 1972; 135: 185-207.
18. Cox DR,. Regression models and life-tables. J R Stat Soc B. 1972; 34: 187-220.
19. Cui Y, Shu XO, Gao YT, Cai H, Tao MH, Zheng W,. Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol. 2006; 163: 645-653.
20. Ma H, Carpenter CL, Sullivan-Halley J, Bernstein L,. The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors-results of a prospective study. BMC Cancer. 2011; 11: 222.
21. Yeung WF, Chung KF, Poon MM, et al. Chinese herbal medicine for insomnia: a systematic review of randomized controlled trials. Sleep Med Rev. 2012; 16: 497-507.
22. Chen R, Moriya J, Yamakawa J, Takahashi T, Kanda T,. Traditional chinese medicine for chronic fatigue syndrome. Evid Based Complement Alternat Med. 2010; 7: 3-10.
23. Chen HY, Lin YH, Wu JC, et al. Prescription patterns of Chinese herbal products for menopausal syndrome: analysis of a nationwide prescription database. J Ethnopharmacol. 2011; 137: 1261-1266.
24. Qu Y, Gan HQ, Mei QB, Liu L,. Study on the effect of Jia-Wei-Xiao-Yao-San decoction on patients with functional dyspepsia. Phytother Res. 2010; 24: 245-248.
25. Xiao Y, Liu YY, Yu KQ, Ouyang MZ, Luo R, Zhao XS,. Chinese herbal medicine liu jun zi tang and xiang sha liu jun zi tang for functional dyspepsia: meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2012; 2012: 936459.
26. He Y, Zheng X, Sit C, et al. Using association rules mining to explore pattern of Chinese medicinal formulae (prescription) in treating and preventing breast cancer recurrence and metastasis. J Transl Med. 2012; 10 (suppl 1): S12.
27. Campbell MJ, Hamilton B, Shoemaker M, Tagliaferri M, Cohen I, Tripathy D,. Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Res. 2002; 22: 3843-3852.
28. Gu G, Barone I, Gelsomino L, et al. Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation. J Cell Physiol. 2012; 227: 3363-3372.
29. Auyeung KK, Woo PK, Law PC, Ko JK,. Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells. J Ethnopharmacol. 2012; 141: 635-641.
30. Gong Y, Li Y, Abdolmaleky HM, Li L, Zhou JR,. Tanshinones inhibit the growth of breast cancer cells through epigenetic modification of Aurora A expression and function. PLoS One. 2012; 7: e33656.
31. Wang Z, Wang D, Han S, et al. Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer. PLoS One. 2013; 8: e56631.
32. Miller KI, Qing C, Sze DM, Neilan BA,. Investigation of the biosynthetic potential of endophytes in traditional Chinese anticancer herbs. PLoS One. 2012; 7: e35953.
33. Perez AT, Arun B, Tripathy D, et al. A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat. 2010; 120: 111-118.
34. Yoshida Y, Wang MQ, Liu JN, Shan BE, Yamashita U,. Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J Immunopharmacol. 1997; 19: 359-370.
35. Ravipati AS, Zhang L, Koyyalamudi SR, et al. Antioxidant and anti-inflammatory activities of selected Chinese medicinal plants and their relation with antioxidant content. BMC Complement Altern Med. 2012; 12: 173.
36. Yang Y, Chin A, Zhang L, Lu J, Wong RW,. The role of traditional Chinese medicines in osteogenesis and angiogenesis. Phytother Res. 2014; 28: 1-8.
37. Zheng KY, Choi RC, Cheung AW, et al. Flavonoids from Radix Astragali induce the expression of erythropoietin in cultured cells: a signaling mediated via the accumulation of hypoxia-inducible factor-1α. J Agric Food Chem. 2011; 59: 1697-1704.
38. Huang XP, Tan H, Chen BY, Deng CQ,. Astragalus extract alleviates nerve injury after cerebral ischemia by improving energy metabolism and inhibiting apoptosis. Biol Pharm Bull. 2012; 35: 449-454.
39. Park OK, Choi JH, Park JH, et al. Comparison of neuroprotective effects of five major lipophilic diterpenoids from Danshen extract against experimentally induced transient cerebral ischemic damage. Fitoterapia. 2012; 83: 1666-1674.
40. Psaty BM, Siscovick DS,. Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction. JAMA. 2010; 304: 897-898.